Questions and Answers: Impurities Found in Certain Generic Angiotensin II Receptor Blocker (ARB) Products
What should health care professionals know? The FDA has determined the recalled lots of valsartan, irbesartan, and losartan products pose […]
TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and […]II
Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018